Overview
Advanced Therapeutics, published by Wiley (Germany), published 912 papers in 2021–2025, and its papers received 6,833 citations in those years. Its h-index is 58 and its two-year mean citedness is 2.98. On the ITS Journal Score it ranks #5,375 of 62,158 ranked journals and #814 of 4,181 in Engineering.
Key figures
Citations count every citation the journal's papers received in these years, including citations to older papers. Two-year mean citedness is OpenAlex's measure of how often recent papers are cited; it is similar in idea to, but not the same as, an impact factor.
Papers and citations by year
| Year | Papers | Citations received | Open-access papers |
|---|---|---|---|
| 2020 | 209 | 4,669 | 91 |
| 2021 | 169 | 2,710 | 88 |
| 2022 | 160 | 1,324 | 59 |
| 2023 | 212 | 1,503 | 138 |
| 2024 | 204 | 915 | 119 |
| 2025 | 167 | 381 | 95 |
What it publishes
The leading research topics of its papers (OpenAlex topic classification). Select a topic to find other journals that publish on it.
Similar journals
Ranked journals that publish on the same topics.
| Journal | Field | Score | Papers 2021–2025 | Open access |
|---|---|---|---|---|
| Cancer Nanotechnology | Engineering | 74.9 | 294 | 100% |
| Journal of Nanotheranostics | Materials Science | 66.3 | 98 | 100% |
| Nano Today | Engineering | 89.6 | 1,727 | 16% |
| Journal of Nanobiotechnology | Engineering | 90.7 | 3,204 | 100% |
| Nanotheranostics | Engineering | 72.4 | 167 | 100% |
| Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology | Biochemistry, Genetics and Molecular Biology | 83.3 | 412 | 49% |
| Nanomedicine Nanotechnology Biology and Medicine | Materials Science | 73.5 | 522 | 37% |
| Exploration | Engineering | 84.7 | 500 | 100% |
Identity and sources
- ISSN-L: 2366-3987
- Print ISSN: 2366-3987
- Publisher: Wiley
- Listed in DOAJ: Not yet checked
- Crossref: Not yet checked
- OpenAlex: S4210200121
- Journal website: onlinelibrary.wiley.com
Figures come from OpenAlex (papers, citations, h-index, topics), Crossref (ISSN check) and DOAJ (open-access listing and fees). They change as records are corrected, so treat them as a dated snapshot. This page does not state whether the journal is indexed in Scopus, Web of Science or PubMed.
Questions
What is the ITS Journal Score of Advanced Therapeutics?
It is 72.6 out of 100, which places it #5,375 among ranked journals. The score combines citation impact (45%), h-index (35%) and size (20%) from open OpenAlex data.
What is the impact factor of Advanced Therapeutics?
This site does not publish Journal Impact Factors, which belong to Clarivate. As an open alternative, its two-year mean citedness in OpenAlex is 2.98.
Is Advanced Therapeutics open access?
55% of its papers from 2021–2025 are recorded as open access.
Does Advanced Therapeutics charge a publication fee?
No fee is recorded in the open data used here. Check the journal's own website for its current fees.